Mark and Howard are joined by Sarah Holland, Chief Business Officer at Swiss biotech CDR Life and President of the Swiss Healthcare Licensing Group, to explore what intelligence looks like in the private sector.

Sarah explains how biotech companies use competitive intelligence, scientific data, market insight, expert networks, conferences, regulatory signals, and even industry gossip to make high-stakes decisions about drug development and partnerships.